Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
复制标题
DOI：
10.1200/jco.2010.32.8112
复制
发表时间：
2011-06-01
影响因子：
45.3
通讯作者：
Carter, H. Ballentine
中科院分区：
文献类型：
--
作者：
Tosoian, Jeffrey J.;Trock, Bruce J.;Carter, H. Ballentine
PurposeWe assessed outcomes of men with prostate cancer encountered in active surveillance.Patients and MethodsSince 1995，a total of 769 men diagnosed with prostate cancer has been followed prospectively（median follow-up，2.7 years; range，0.01 to 15.0 years）on active surveillance.入选标准为极低风险癌症，由临床分期（T1 c）、前列腺特异性抗原密度< 0.15 ng/mL和前列腺活检结果（Gleason评分）定义
PurposeWe assessed outcomes of men with prostate cancer enrolled in active surveillance.Patients and MethodsSince 1995, a total of 769 men diagnosed with prostate cancer have been followed prospectively (median follow-up, 2.7 years; range, 0.01 to 15.0 years) on active surveillance. Enrollment criteria were for very-low-risk cancers, defined by clinical stage (T1c), prostate-specific antigen density < 0.15 ng/mL, and prostate biopsy findings (Gleason score